| Market Cap | ₹45Cr | 
| ROE | -4.40% | 
| P/E Ratio(TTM) | -43.25 | 
| EPS(TTM) | -0.44 | 
| P/B Ratio | 1.83 | 
| Dividend Yield | 0.00% | 
| Industry P/E | 40.62 | 
| Book Value | 10.40 | 
| Debt to Equity | 0.02 | 
| Face Value | 10 | 
| Parent Organisation | Kabra Drugs Limited | 
| BSE Symbol | 524322 | 
| COMPANY | 52 WEEK  | MARKET PRICE | P/E Ratio  | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%)  | 61.33  | ||
| Gland Pharma | NA (0.00%)  | 42.19  | ||
| Ajanta Pharma | NA (0.00%)  | 32.58  | ||
| Eris Lifesciences | NA (0.00%)  | 52.95  |